Best Cannabinoid Science Podcasts (2025)

1
Exploring the Future of Cannabinoid & Psychedelic Therapies with Joel Latham of Incannex Healthcare 31:32

Play Pause

17m ago31:32

31:32

In this episode of the Xtalks Life Science Podcast, Senior Life Science Journalist Ayesha Rashid speaks with Joel Latham, CEO, president and director of Incannex Healthcare, to discuss how the company is advancing cannabinoid and psychedelic therapies for chronic conditions like sleep apnea, rheumatoid arthritis and anxiety disorders. Joel has more…

1
$28.4B Hemp Industry Can’t Be Put Back in the Bottle ft Jim Higdon 47:52

8h ago47:52

47:52

Chapters 00:00 Introduction and Current State of the Hemp Industry 03:04 Bipartisan Support and Legislative Challenges 05:46 The Path to a One Plant Solution 08:54 California's Unique Position in the Hemp Debate 11:57 The Impact of Alcohol Industry on Hemp Legislation 14:57 The Future of Hemp and Spirits Collaboration 26:03 Navigating Legislative C…

1
Steven Puri: Flow, Focus & Your Great Work | Episode 139 1:10:28

4h ago1:10:28

1:10:28

In this episode, I talk with Steven Puri, co-founder of the focus app Sukha and former Hollywood executive, about focus and flow — what it feels like, why it matters, and how to increase it. We cover a range of tools and techniques, including: sound, physical space, to-do lists, community, solitude, time of day, and simple items like a pencil, pape…

1
The Business Case For Health Economics And Outcomes Research With ISPOR's Rob Abbott 57:58

1d ago57:58

57:58

We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Rob Abbott, CEO of ISPOR, explains how startup and early-stage clinical drug development companies benefit from conducting health economics and outcomes research (HEOR), and not just with patients and commercial payers. HEOR, viewed as a strate…

1
Largest Medical Cannabis & Cancer Study Ever: Can These Findings Push Rescheduling? ft Ryan Castle 48:40

8d ago48:40

48:40

If you were given some of the worst news in the world, wouldn’t you expect your doctors to use every tool available? What if one of those tools could save millions of lives—and the science is already here? The world’s largest medical cannabis and cancer study—10,000 papers, ranked in the top 5% globally—shows overwhelming evidence that cannabis has…

1
Driving Innovation in Oncology: Insights from Jeff Glazier of General Oncology 33:38

6d ago33:38

33:38

In this episode of the Xtalks Life Science Podcast, host Ayesha Rashid, speaks with Jeff Glazier, CEO and founding member of General Oncology. General Oncology is focused on advancing innovative therapies that address some of the greatest unmet needs in oncology. At General Oncology, Jeff has overseen everything from corporate strategy and clinical…

1
Paul Taylor: To the Edge of Yourself — Becoming Unbreakable | Episode 138 1:12:08

6d ago1:12:08

1:12:08

In this episode, I talk with Dr. Paul Taylor, author, neuroscientist, exercise physiologist, and host of The Paul Taylor Podcast. He is an expert in hardiness, the science of turning stress into strength. Modern life is quietly weakening us through the way we eat, move, sleep, socialize, and use technology. By introducing stress, challenge, and dis…

1
Cannabinoid And Psychedelic Combinations With Incannex Healthcare's Joel Latham 57:27

8d ago57:27

57:27

We love to hear from our listeners. Send us a message. On this week's episode, Joel Latham, President and CEO at Incannex Healthcare, talks about developing cannabinoid and psychedelic combination therapies for conditions as diverse as sleep apnea, rheumatoid arthritis, and generalized anxiety disorder. Joel walks through his funding strategy for t…

1
EP124 Lab Analytics for Patients: Best Practices to Get Results with Amber Wise PhD 1:44:24

11d ago1:44:24

1:44:24

Cannabis lab analytics are essential for making reliable cannabis tinctures and oils for patients. On episode 124 of Shaping Fire, host Shango Los talks with chemist Amber Wise, PhD about contacting labs, choosing your tests, how to interpret them, and how to use the results to make better tinctures, oils and edibles.…

1
Strategy Truths & Lies, Mature Industries Already Know ft. Mitchell Osak 56:08

15d ago56:08

56:08

Cannabis is chaotic by design. Vertical integration forces operators to run six or seven businesses at once — then replicate that model across states with different regulations, all without economies of scale. It’s no wonder the industry feels messy. The bigger problem? Too many companies are chasing the wrong metrics and ignoring the lessons other…

1
The Next Generation of Cell Therapy with Cartherics’ COO Dr. Ian Nisbet 55:49

13d ago55:49

55:49

In this episode of the Xtalks Life Science Podcast, we dive into the cutting edge of cell therapy innovation with Ian Nisbet, PhD, chief operating officer (COO) and co-founder of Cartherics, an Australian biotech company developing next-generation cell therapies for difficult-to-treat diseases like cancer and endometriosis. Dr. Nisbet also acts as …

1
Tamas Konya: Qi Gong — Reconnect to Your Life Force | Episode 137 1:17:35

13d ago1:17:35

1:17:35

In this episode, I talk with Qi Gong practitioner and holistic life coach Tamas Konya. We discuss the philosophy and practice, Qi Gong, its benefits, how it has helped Tamas, and how it can help you too. Connect and Learn More: Website: tamascoach.com LinkedIn: Tamas Konya Facebook: Tamas Konya Instagram: @tamascoach YouTube: @tamascoach Resources …

1
Dye Drug Conjugates For Cancer With Lahjavida's Lyle Small 58:25

15d ago58:25

58:25

We love to hear from our listeners. Send us a message. On this week's episode, Lyle Small, Founder and CEO at Lahjavida, a dye drug conjugate start-up, talks about creating the famous color-changing technology that turned the mountains blue on cold Coors Light beer cans, to launching a dye-drug conjugate startup developing targeted cancer therapies…

1
3, 2, 1… SOLOOOOO! | Episode 136 10:35

19d ago10:35

10:35

What do you do when you have three interviews scheduled and no one shows up? You make a SOLOOOOO episode. Mikey’s back, in his classic state - all alone. This is a musing on what to do when you’ve planned, prepared, and done everything you could, but reality has other ideas. What do you do? Keep going, keep trying, re-channel that energy into somet…

1
THC Is an Ingredient, Where Pharma, MSOs & Hemp Collide, ft. Zach Edge 43:08

22d ago43:08

43:08

THC is an ingredient. Cannabinoids will be treated like standardized inputs across pharma, licensed cannabis, and hemp—and the future winners are hedging until there’s clarity. What got you here won’t get you there. The next phase needs a new playbook: ops tweaks aren’t enough; strategy has to change. Near term, expect Schedule III to unlock e-phar…

1
Lori Tsugawa: Japanese Wisdom for Brain Recovery | Episode 135 1:05:41

20d ago1:05:41

1:05:41

In this episode, Lori Tsugawa, author of Let the Samurai Be Your Guide, shares her journey of overcoming traumatic brain injuries (TBIs) by drawing on her Japanese heritage and values. We explore Japanese concepts like bushido (the way of the warrior), ikigai, and ganbaru (never giving up), and discuss how you can apply these principles to your own…

1
Why MASH Matters: The Next Steps in Liver Disease Innovation with 89bio’s Rohan Palekar 35:54

20d ago35:54

35:54

In this episode of the Xtalks Life Science Podcast, Editor-in-Chief Vera Kovacevic speaks with Rohan Palekar, CEO of 89bio, about one of the fastest-growing public health challenges: metabolic dysfunction-associated steatohepatitis (MASH), also known as fatty liver disease. MASH is projected to affect more than 27 million Americans by 2030, yet it …

1
Investing In The Biostack With Modi Ventures' Sahir Ali, Ph.D. 57:54

22d ago57:54

57:54

We love to hear from our listeners. Send us a message. On the Business of Biotech this week, Sahir Ali, Ph.D., founder and general partner at Modi Ventures, a family office investing at the intersection of technology and biology, talks about adapting the Markowitz model to improve returns and balance risk, his concept of the "biostack" for making d…

1
Sensory Science Unlocked, Beyond THC, Inside True Terpenes ft. Dan Cook 51:32

28d ago51:32

51:32

$8 billion in products hit shelves each year with True Terpenes inside. The real edge? Turning sensory science—backed by data—into products that connect and fill clear gaps in the market. We break down what cannabis can borrow from wine (shared language, guided discovery), where that analogy stops, and why toxicology and standards are the new trust…

1
Eric Zwigart: The ADHD Brain in Business and Faith | Episode 134 1:01:58

30d ago1:01:58

1:01:58

In this episode, I talk with Eric Zwigart, CEO of Rock Solid Capital Investments, about how ADHD has shaped his career, faith, and life. Eric shares how ADHD shows up for him — both the challenges, like distraction, difficulty listening, and time blindness, and the advantages, including intense focus, pattern recognition, and creative problem-solvi…

1
Bridging Aesthetics and Therapeutics in Dermatology with Galderma’s Dr. Bill Andriopoulos 35:55

27d ago35:55

35:55

In this episode of the Xtalks Life Science Podcast, Senior Life Science Journalist Ayesha Rashid connects with Bill Andriopoulos, PhD, Vice President of Medical Affairs at Galderma US, to discuss the future of patient-centered dermatology across both medical and aesthetic care. Galderma is focused on advancing science-based innovations in the derma…

1
Improving Cardiovascular Outcomes With Immediate Therapeutics' Atul Deshpande, Ph.D. 1:04:36

29d ago1:04:36

1:04:36

We love to hear from our listeners. Send us a message. On this week's episode, Atul Deshpande, Ph.D., CEO at Immediate Therapeutics, talks about partnering with American cities to conduct clinical trials during ambulance rides to the hospital, with the goal of preserving heart function and reducing mortality related to acute cardiovascular events, …

1
Dr. Greenhouse: The #1 Mistake Killing Your Plants ft. Nadia Sabeh 1:03:19

1M ago1:03:19

1:03:19

What if keeping the room a little too dry is killing your plants? Humidity—and the HVAC that controls it—drives plant health, but air isn’t uniform across the room. The fix isn’t more AC; it’s dialing VPD so humidity, lights, airflow, and irrigation work together. Get it wrong and you lose yield and fail tests; get it right and buds stay sticky, he…

1
The Neuroscience of Weight Regulation with Courage Therapeutics’ Dr. Roger Cone 51:16

1M ago51:16

51:16

In this episode of the Xtalks Life Science Podcast, Senior Life Science Journalist Ayesha Rashid speaks with Dr. Roger Cone, PhD, founder of Courage Therapeutics, professor at the University of Michigan, a member of the National Academy of Sciences and a leading authority on the neuroscience of weight regulation. Dr. Cone shares insights from over …

1
Jennifer Dall: Understanding ADHD in Women | Episode 133 56:25

1M ago56:25

56:25

In this episode, I talk with ADHD specialist Jennifer Dall about ADHD in women. We discuss the symptoms, features, different forms, possible causes, benefits, overlaps with other conditions, tools that can help, and more. Connect and Learn More 🔗Website: adhdholistically.com 📷Instagram: @adhd.holistically 💬Threads: @adhd.holistically Resources Book…

1
Building A Biotech Incubator And Accelerator With Swiss Rockets Founder And CEO Vladimir Cmiljanovic, Ph.D. 52:07

1M ago52:07

52:07

We love to hear from our listeners. Send us a message. On this week's episode, ex-handballer Vladimir Cmiljanovic, Ph.D., Founder and CEO at Swiss Rockets, talks about co-discovering bimiralisib with his sister Natasa Cmiljanovic, Ph.D. (and COO at Swiss Rockets), losing his company to a hostile takeover, buying the company back, and building out S…

1
Richie Proud on the iAnthus Turnaround: Why Selling Arizona Fueled Core-Market Growth 55:05

1M ago55:05

55:05

What if the smartest growth move is cutting—on purpose? Turnarounds aren’t financial stories—they’re operational ones. Growth-at-all-costs is out. The new playbook: prune non-core assets, concentrate resources in high-return states, and speed the path from cultivation to checkout. This week we sit down with Richie Proud, CEO of iAnthus, to discuss:…

1
Exploring Immunomodulation Without Immunosuppression with Artax Biopharma’s Dr. Rob Armstrong 37:53

1M ago37:53

37:53

In this episode of the Xtalks Life Science Podcast, host Ayesha Rashid speaks with Rob Armstrong, PhD, CEO of Artax Biopharma, a company pioneering a novel class of oral small molecule drugs known as Nck modulators to treat autoimmune diseases. Unlike traditional therapies that suppress the immune system, Artax’s approach aims to restore immune bal…

1
Biotech Product Partnership with Coya Therapeutics' Arun Swaminathan, Ph.D. and Dr. Reddy's Milan Kalawadia 52:37

1M ago52:37

52:37

We love to hear from our listeners. Send us a message. On this week's episode, Milan Kalawadia, CEO, North America, Dr. Reddy's Laboratories, and Arun Swaminathan, Ph.D., CEO, Coya Therapeutics discuss their unique partnership to develop COYA 302, a novel dual-mechanism immunotherapy for the treatment of ALS. The partnership pairs Coya's scientific…

1
Secrets Behind Failed Cannabis Builds: Where Every Team Needs to Look Now ft. David Fettner 49:36

2M ago49:36

49:36

Most cannabis facilities fail before the first wall goes up. Most assume it’s because of money — but they’re wrong. It’s because no one asked the right questions. The question you need to ask now is: Where should we be looking to set ourselves up for long-term success? Asking the right questions is critical — because decisions made for today can be…

1
Advancing Neurotherapeutics for Fragile X and Beyond with Spinogenix CMO Dr. Craig Erickson 37:11

2M ago37:11

37:11

In this episode of the Xtalks Life Science Podcast, Ayesha speaks with Craig Erickson, MD, chief medical officer at Spinogenix and a leading expert in translational neurodevelopmental research. Dr. Erickson shares insights into Spinogenix’s work on restoring synapses to reverse cognitive and motor decline in conditions like Fragile X Syndrome, ALS,…

1
Jenae Alt: The Effects of CBD and Cannabinoids | Episode 132 1:08:39

2M ago1:08:39

1:08:39

In this episode, I talk with actress and entrepreneur Jenae Alt about cannabinoids like CBD, CBG, and THC, terpenes, and the effects they can create — including relaxation, pain relief, better sleep, creativity, presence, focus, energy, immune support, beauty, sexual pleasure, and overall well-being. We also discuss delivery methods, other natural …

1
How To Hire And Build A Winning Executive Team With Occam Global's Bill Holodnak 58:11

2M ago58:11

58:11

We love to hear from our listeners. Send us a message. On this week's episode, Bill Holodnak, Cofounder and CEO of Occam Global, a life sciences executive recruitment firm (and occasional investor), shares insights from his decades of experience pairing executives with drug development companies, and talks about the psychology of successful biotech…

1
The ROI of Pre-Roll Automation: Scaling Quality, Reducing Labor, and Hitting 20K+ a Day ft. Shahar Yamay 39:00

2M ago39:00

39:00

Every investment is just an ROI calculator. Automation feels risky—until you run the numbers. It doesn’t kill craftsmanship—it scales it. Growing your pre-roll category usually means balancing sales growth with hand-filling teams to maintain quality. But what if you could do both? What if you could leverage best-in-class automation to hit your numb…

1
Driving Neuro Innovation with Neurizon Therapeutics CEO Dr. Michael Thurn 44:15

2M ago44:15

44:15

In this episode of the Xtalks Life Science Podcast, Ayesha speaks with Michael Thurn, PhD, Managing Director & CEO, Neurizon Therapeutics, a company focused on advancing treatments for neurodegenerative diseases, including ALS, with expansion efforts in Alzheimer’s, Parkinson’s, Huntington’s and others. With over 25 years of experience in biotech i…

1
The Generalist Biotech CEO With Seekyo's Oury Chetboun 52:03

2M ago52:03

52:03

We love to hear from our listeners. Send us a message. On this week's episode, Oury Chetboun, co-founder and CEO of Seekyo, a French biotech, talks about the range of experiences that prepared him to lead a company focused on developing innovative solid tumor treatments that target functional proteins in the tumor micro-environment. Chetboun talks …

1
Keep Your Eye on Ohio: Why California’s Failures Are Michigan’s Success, and the Global Cannabis Landscape ft. Hirsh Jain 56:44

2M ago56:44

56:44

What’s the real goal of a legal cannabis market? If it’s to replace the illicit market, create safe access, and drive tax revenue—then why is California, the world’s 4th largest economy, failing while Michigan is thriving? Despite California’s size and cultural dominance, cannabis sales are shrinking, cities are refusing to opt in, and the illicit …

1
Restoring Synapses to Fight ALS, Alzheimer’s and More with Spinogenix CEO Dr. Stella Sarraf 38:49

2M ago38:49

38:49

In this episode of the Xtalks Life Science Podcast, Ayesha speaks with Stella Sarraf, PhD, founder, CEO and director of Spinogenix, a company pioneering neurodegenerative therapeutics designed to restore synapses with the potential to reverse cognitive and motor decline in conditions such as ALS, Alzheimer’s disease, schizophrenia and other neurolo…

1
Dustin Dunbar: Breaking Free from the Alcohol Matrix and Finding Real Joy | Episode 131 1:01:51

2M ago1:01:51

1:01:51

In this episode, I talk with Dustin Dunbar, author of You're Doing Great! (And Other Lies Alcohol Told Me) and founder of Alcohol-Free Revolution. We discuss the illusion that alcohol benefits us, how calling it what it truly is—ethanol—can reframe our perspective, and why quitting doesn’t have to be a lifelong struggle. Dustin shares the dream tha…

1
Innovating On The Frontier Of Radiopharmaceuticals With RadioMedix's Ebrahim Delpassand, M.D. 54:07

2M ago54:07

54:07

We love to hear from our listeners. Send us a message. On this week's episode, Ebrahim Delpassand, M.D., founder, CEO, and chairman of the board at RadioMedix talks about his personal journey standing up and growing a radiopharmaceutical company focused on oncology. Dr. Delpassand discusses the current trends in radiopharmaceutical drug development…

1
The Cannabis Titanic: The Reset Ahead, Matt Karnes on What the Numbers Say 43:04

2M ago43:04

43:04

Debt is coming due — and we’re approaching a point of no return. At this stage, it’s not if there will be fallout — it’s who survives it. The surface-level view of the cannabis industry hides deep financial issues that only become clear when you dig into the numbers. And that’s exactly what Matt Karnes has been doing for years. From cash flow strai…

1
Championing the Patient Voice with Ardelyx’s Chief Patient Officer Dr. Laura Williams 38:14

2M ago38:14

38:14

In this episode of the Xtalks Life Science Podcast, Ayesha Rashid speaks with Laura Williams, MD, MPH, chief patient officer at Ardelyx, a company developing and commercializing first-in-class medicines for diseases like chronic kidney disease (CKD) and irritable bowel syndrome (IBS). Dr. Williams brings nearly 30 years of experience in clinical de…

1
Building An Efficient Biopharma With South Rampart Pharma's Hernan Bazan, M.D. 45:41

2M ago45:41

45:41

We love to hear from our listeners. Send us a message. On this week's episode, Dr. Hernan Bazan, M.D., co-founder and CEO at New Orleans-based South Rampart Pharma, talks about building an ultra-lean drug development company to address an unmet need observed in his own patients as a surgeon: safe treatments for acute pain. Dr. Bazan explains his st…

1
Organigram’s Competitive Edge: Paolo De Luca on BAT, M&A Strategy, and the Cannabis Long Game 54:43

3M ago54:43

54:43

Built to last. That’s not just a slogan — it’s a strategy. In an industry driven by short-term survival, the cannabis space often feels like a rollercoaster. Financial pressures and market volatility push companies to chase quarters instead of building moats. But what if you could play the long game? What if you could invest in domain knowledge, de…

1
Inside AI-Powered Drug Discovery with Gain Therapeutics’ CEO Gene Mack 31:23

3M ago31:23

31:23

In this episode of the Xtalks Life Science Podcast, Vera Kovacevic speaks with Gene Mack, CEO and President of Gain Therapeutics, a company focused on AI-driven small molecule discovery for diseases with high unmet medical needs. With over 25 years of leadership across biopharma, capital markets and corporate strategy, Gene shares his unique perspe…

1
Phillip Wilson: The Adventures of Thinker and Feeler — Saunas, Freedom, and Life | Episode 130 1:51:57

3M ago1:51:57

1:51:57

In this episode, I talk with health guru, spiritual traveler, former math prodigy, and president of Relax Saunas of Momentum, Phillip Wilson, about his philosophies on life and death. Reflecting on his own journey, we explore some of the keys to a good life, including balancing thinking and feeling, meditation, contemplation, presence, listening, p…

1
The Business And Science Of Obesity With Roger Cone, Ph.D., Founder Of Courage Therapeutics 54:23

3M ago54:23

54:23

We love to hear from our listeners. Send us a message. On this week's episode, Roger Cone, Ph.D., Founder and Chair of the Scientific Advisory Board at Courage Therapeutics, talks about discovering obesity-related protein receptors in the brain, how he spun his academic discoveries out into a biotech company developing new obesity drugs, the need f…

1
The Michelin-Star Experience? Gibran Washington on What Customers Actually Want 49:52

3M ago49:52

49:52

What if buying cannabis felt more like a Michelin-star dining experience than a traditional retail transaction? Where the staff doesn’t just sell—they guide, educate, and tailor every recommendation to how you want to feel. No guessing. Just clarity, confidence, and trust—rooted in science-backed evidence. That’s the vision behind Ethos Cannabis. W…

1
Targeting Mast Cells: A New Frontier in Allergy & Inflammation with Jasper Therapeutics’ CMO Dr. Edwin Tucker 38:01

3M ago38:01

38:01

In this episode of the Xtalks Life Science Podcast, host Ayesha Rashid speaks with Edwin Tucker, MD, MBA, Chief Medical Officer (CMO) at Jasper Therapeutics, about innovative approaches to treating chronic mast cell diseases such as asthma, food allergies and IBS. Dr. Tucker has over 30 years of clinical drug development experience, with past roles…

1
Steffani LeFevour: How to Be a Happy Mom — Simple Tools for Calm and Joy | Episode 129 58:13

3M ago58:13

58:13

In this episode, I talk with Steffani LeFevour, happiness coach and author of You Are A Badass Mom, about the real challenges of motherhood — and how to move through them using tools that support your body, mindset, and actions. We cover practices like gratitude, focusing on what’s going well, redirecting your attention to what you do want, journal…